Updated
Updated · Bloomberg · Jul 3Carlyle Hires JM Financial, Goldman for $400 Million India RCM IPO
1 articles · Updated · Bloomberg · Jul 3Summary
- $400 million is the target Carlyle is weighing for a potential IPO of Knack RCM, its India-based healthcare revenue cycle management business.
- JM Financial and Goldman Sachs have been hired to advise on the deal, with Carlyle likely to add more bankers later in the process.
- The share sale could launch later this year or in early 2027, according to people familiar with the private deliberations.
Insights
With Carlyle's earnings down, is this AI healthcare IPO a strategic exit or a necessary cash grab in a hot market? In a market favoring mega-IPOs, can Carlyle's AI venture achieve its $400M target without a steep valuation discount?